In looking for answers to the problem of US drug shortages during the coronavirus pandemic, members of the Senate Finance Committee and the US Food and Drug Administration officials who testified at a recent committee hearing focused less on widespread concerns of vulnerability to China and more on how to fix persistent domestic market failures.
US Drug Shortages In COVID-19 Era: A Domestic Problem With Domestic Solutions
Rather than rail at China, senators explored causes and corrective actions for drug shortages that are closer to home.
